📰 Emerging Focus News
Page 2 - Emerging Focus News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Emerging Focus. Real-time updates on events, politics, business and more.
July 20, 2022
/PRNewswire/ -- The "Biosensors Market: Focus on Drug Discovery and Development - Distribution by Type of Biosensor, Type of End User and Key Geographies -...
June 21, 2022
/PRNewswire/ -- The "DNA Synthesis Technologies and Services Market, Distribution by Method of DNA Synthesis, Key Applications Areas, Company Size, and Key...
June 21, 2022
/PRNewswire/ -- The "The Vaccine Adjuvants Market by Type of Vaccine Adjuvant, Route of Administration, Target Therapeutic Area and Key Geographies: Industry...
June 16, 2022
/PRNewswire/ -- The "Anti-aging Therapeutics Market - Distribution by Type of Molecule, Type of Aging and Key Geographies - Industry Trends and Global...
June 15, 2022
/PRNewswire/ -- The "Global Therapeutic Vaccines Market Distribution by Type of Vaccine, Method of Vaccine Composition, Type of Therapy, Target Disease...
March 22, 2022
/PRNewswire/ -- The "Exosome Development and Manufacturing Services Market, 2022-2035" report has been added to ResearchAndMarkets.coms offering. The "Exosome...
March 21, 2022
/PRNewswire/ -- The "Gene Editing beyond CRISPR Market: Focus on Zinc Finger Nucleases, Transcription Activator-Like Effector Nucleases and Meganucleases...
November 2, 2021
Gold thin films can be used in a range of applications from cell culture to sensor technology. Learn more about this nanotechnology here.
April 29, 2021
Share this article Share this article ResearchAndMarkets.coms offering. The "Non-Viral Drug Delivery Systems: Focus on Intracellular Technologies and Intracellular Biologics Market, 2021-2030" report features an extensive study of the current landscape and the likely future opportunities in intracellular drug delivery technologies market for the next 10 years. One of the key objectives of the report was to estimate the existing market size and identify potential future growth opportunities for ...
April 6, 2021
Share this article Share this article ResearchAndMarkets.coms offering. Since the approval of Vitravene (for the treatment of cytomegalovirus retinitis) in 1998, antisense oligonucleotide (ASO) therapies have evolved into a prominent class of therapeutics. In addition to the seven drugs, based on such molecules, that are commercially available, around 160 candidates are under development. Examples of recently approved antisense therapeutics include (in reverse chronological order) Viltepso (duc...